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Temporal analysis of Acinetobacter calcoaceticus-baumannii
complex isolates in a large, US healthcare system demonstrated
decreased occurrence of antibiotic-susceptible isolates between
November and May, while resistant isolate occurrence was temporally stable. This resulted in 50%–100% seasonal increases of
resistance rates. This work offers insight into the phenomenon
of Gram-negative pathogen seasonality.
Key words. Acinetobacter baumannii; multidrug resistance;
seasonality.
INTRODUCTION

Acinetobacter calcoaceticus-baumannii complex (Abc) is a major
global health threat due to its ability to survive in multiple
environments and its association with high levels of antibiotic
resistance. Though most notorious for their role in hospitalacquired infections, multiple studies report that 25%–65% of
Abc clinical isolates are obtained in ambulatory settings or within
48–72 hours of hospital admission [1–3]. Further understanding
Abc epidemiology is essential for developing interventions to curb
the growing impact of multidrug-resistant (MDR) Abc infections.
Many Gram-negative pathogens, including Abc, increase
in incidence during warmer, summer months, a phenomenon
commonly referred as seasonality [4]. Accurate characterization of these seasonal trends is important for effective surveillance and infection control efforts. However, reports from
single center studies conflict on Abc seasonality. For example, a
9-year Korean study of 3520 unique Abc isolates demonstrated

that community-acquired isolates (n = 922), but not hospitalacquired isolates (n = 2598), had higher rates of incidence during
warmer months [2]. An 11-year Pennsylvania study of 1476
isolates reported that non-MDR isolates (n = 692) exhibited
seasonality, but contemporaneous MDR Abc isolates (n = 784)
lacked seasonality [5]. In contrast, a 7-year study performed in
Baltimore reported that all Abc isolates (n = 1444) exhibited
seasonality independent of duration of hospital admission and
antibiotic resistance [1]. We performed a retrospective analysis of Abc clinical isolates identified in and around St. Louis,
Missouri, over a decade. Our aim was to analyze this cohort, of
which over 45% of isolates were MDR, to investigate Abc seasonality in different epidemiological subgroups.
METHODS

Our retrospective analysis will be described elsewhere (unpublished data). Briefly, we compiled clinical and microbiology data
on 1948 Abc isolation events from January 1, 2007, through
December 31, 2016, in 11 BJC HealthCare System (BJC) hospitals
located in and around Saint Louis. Only the first isolation event
(index culture) per patient age >18 years was included. Similar
to prior studies [1, 2], isolates were labelled as hospital-acquired
(HA) if the index culture was obtained ≥48 hours after hospital
admission, and all other isolates were labelled as nonhospitalacquired (nHA). Isolates were also grouped according to specimen source as respiratory, skin and soft tissue or musculoskeletal
(SST/MSK), urinary, endovascular, or other. For antibiotic susceptibility analysis, isolates were classified as resistant if they were reported as resistant or intermediate per the Clinical and Laboratory
Standards Institute’s guidelines [6]. The following antibiotics
were grouped into classes: meropenem and imipenem (MEM/
IPM) as carbapenems; ciprofloxacin and levofloxacin (CIP/LVX)
as fluoroquinolones; piperacillin-tazobactam and ticarcillinclavulanic acid (TZP/TIM) as antipseudomonal penicillins plus
β-lactamase inhibitor; and tetracycline and doxycycline (TET/
DOX) as tetracyclines. If an isolate was nonsusceptible to any antibiotic in a class, it was labelled resistant for that class.
Seasonality Analysis
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According to the month an index culture was obtained, isolates
were grouped into quarters as follows: December (from prior
year) through February as Quarter 1 (Q1); March through
May as Quarter 2 (Q2); June through August as Quarter 3
(Q3); and September through November as Quarter 4 (Q4).
The number of isolates per quarter was plotted, starting with
Q2 in 2007 (“07Q2”). To normalize isolate occurrence across
multiple years for comparative analysis, we converted quarterly
occurrence to a percentage of annual isolates (ie, [# of isolates
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in a quarter]/[# of isolates in all 4 quarters in the corresponding
year] × 100 = “normalized occurrence”). Using this method
we expect 25% of annual isolates, on average, to occur in each
quarter, in the absence of seasonal variation. We also determined the resistance rates exhibited by isolates in each quarter.
Normalized occurrence and resistance rates were averaged for
all Q1–Q4 in the study period. Pairwise comparisons between
quarters (eg, Q1 vs Q2, Q1 vs Q3, etc.) were performed using
2-sample independent t test analysis with SPSS v25 (IBM, USA).
To compare our cohort to those from prior analyses [1, 2, 5], we
performed subgroup seasonality analysis according to whether
isolates were HA or nHA, whether they were susceptible or resistant to an antibiotic, and according to isolate tissue source.
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We plotted the 10-year cumulative total of isolates obtained in
each month, grouped according to susceptibility to gentamicin
(GM), carbapenems (MEM/IPM), fluoroquinolones (CIP/LVX),
or trimethoprim-sulfamethoxazole (SMX). As seen in Figure
1A, there was a peak in susceptible isolates between June and
November without a corresponding peak for resistant isolates.
These diverging epidemiological behaviors resulted in net antibiotic resistance rates being lowest in September or October
and highest in February. Similar observations were made when
examining isolate occurrence and resistance rates by quarter:
there were annual peaks of Abc in Q3 and Q4, while resistance
rates peaked during Q1 and Q2 (Supplementary Figure S1).
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Figure 1. Seasonality among antibiotic-susceptible, but not -resistant, Abc isolates. A, The cumulative total (solid lines, left axis) and antibiotic resistance rates (dotted
lines, right axis) of isolates obtained in each month (1–12, January through December) over the study period. Graphs depict numbers of isolates that are susceptible (gray line)
or resistant (black line) to each antibiotic or antibiotic class (GM, gentamicin; MEM/IPM, meropenem/imipenem; CIP/LVX, ciprofloxacin/levofloxacin; SMX, trimethoprim/sulfamethoxazole); B, Total, hospital-acquired (HA), and nonhospital-acquired (nHA) Abc cases per quarter (YY–QQ) are plotted with solid lines. Corresponding quarterly MEM/
IPM resistance rates are plotted with dotted lines. Shaded areas highlight peaks in seasonal occurrence in Q3 and Q4. C,D,E, Average proportion of annual isolates occurring
in each quarter, according to Abc subgroups. In panel C, isolates were grouped into total, HA, and nHA cases. In panels D and E, HA and nHA isolates (panel D) and isolates
from each anatomical source (panel E), were grouped into total (all isolates with susceptibility data), MEM/IPM resistant (R) and susceptible (S) isolates. Color key for panels
C–E is located in panel C. Error bars represent standard deviations. Multi-year averages for each quarter were compared to corresponding Q1 average by independent t test.
*, P < 0 .05; #, P ≤ 0 .001.
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DISCUSSION

Consistent with prior observations [5], we found that Abc seasonality was restricted to antibiotic-susceptible isolates. Seasonal
cycling of antibiotic-susceptible, but not antibiotic-resistant, Abc
resulted in seasonal fluctuations in antibiotic resistance rates.
This phenomenon held true for all tested antibiotics and among
isolates from different epidemiologic compartments. As reported
by others [2], no seasonality was detected among HA isolates.
Subgroup analysis, however, revealed higher Q3 and Q4 occurrence of antibiotic-susceptible, but not resistant, HA isolates. It is
possible that the high proportion of HA resistant isolates masked
the seasonality of susceptible HA isolates in this and prior studies.
Seasonal variation was first described in Acinetobacter in
the 1970s, and since then has been described in many other
Gram-negative and nosocomial infections [4]. The mechanisms
mediating seasonality remains unclear. It has been argued that
warmer, humid conditions or summer-associated host behaviors
lead to a bloom of pathogenic bacteria [1, 2]. However, seasonality
has been observed in tropical environments where temperature
remains relatively stable throughout the year [7]. Furthermore,
climate-dependent models do not explain the lack of seasonality among resistant Abc isolates. Notably, seasonality analyses
typically have not controlled for seasonal antibiotic prescribing
behaviors. A winter-associated increase in community

antibiotic prescriptions has been repeatedly demonstrated [8, 9]
and temporally-linked to seasonal increases in resistance rates
among common human pathogens [8, 10]. It is possible that the
higher use of community antibiotics (eg, tetracyclines, macrolides,
sulfonamides, etc.) during winter months indirectly suppresses
drug-susceptible organisms, mediating Gram-negative seasonality. This would explain the observation of decreased overall
Gram-negative pathogen incidence and increased resistance rates
during colder months (and vice versa). Furthermore, in Abc,
where resistance to various antibiotics is frequently genetically
linked through chromosomal and, to a lesser extent, plasmidencoded resistance islands [11], pressure from antibiotic use in
the community has the potential to select for resistance to multiple other drugs (eg, aminoglycosides, carbapenems, etc.).
Our findings have potentially large clinical and research
implications. First, predictable seasonal changes in antibiotic resistance rates can help inform antibiotic choice for
Abc infections while awaiting susceptibility testing results.
Furthermore, our findings highlight why surveillance studies
must account for annual fluctuations in resistance rates. For example, a study on Abc resistance rates analyzing isolates only
obtained from June to October may mistakenly underestimate
annual resistance rates. Finally, the potential link between community antibiotic practices and multidrug resistance must be
further investigated, as establishing this association would emphasize the urgency to restrict unnecessary antibiotic usage, especially during late fall and winter months.
Our study is limited by its retrospective, single-regional
healthcare system design and by examination of a single group
of Gram-negative pathogens. However, the putative link between antibiotic resistance and seasonality is consistent with
prior observations of Abc [2, 5] and other Gram-negative
pathogens [8, 10]. In this unadjusted analysis, we cannot exclude unmeasured confounders that could influence the seasonality of drug-resistant phenotypes. Future studies should
directly address whether seasonality in other Gram-negative
pathogens also is correlated to drug susceptibility and whether
selective pressure arising from seasonal antibiotic usage is the
principle factor contributing to seasonal trends in incidence
and resistance rate. Regardless, our findings suggest that future investigations on pathogen seasonality should control for
fluctuations in local antibiotic usage and susceptibility rates.
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We next tested whether Abc seasonality was exhibited in
different populations. Both total isolates (n = 1948) and nHA
isolates (n = 1202, 61.7%) exhibited annual peaks during Q3
and Q4 (Figure 1B), resulting in a higher proportion of isolates
during Q3 and Q4 compared to Q1 and Q2 (Figure 1C). Though
the occurrence of HA isolates (n = 746, 38.3%) was indistinguishable between quarters (Figure 1C), MEM/IPM resistance
rates among both nHA and HA isolates repeatedly peaked
during Q1 and Q2 (Figure 1B). When HA and nHA isolates
were grouped according to carbapenem susceptibility, a higher
proportion of susceptible HA and nHA isolates occurred in
Q3 and Q4, while carbapenem-resistant HA and nHA isolates
lacked seasonal variation (Figure 1D). Similarly, when Abc cases
were grouped according to anatomic site of isolation, only susceptible isolates exhibited increased occurrence during Q3 and
Q4 (Figure 1E). The association between antibiotic susceptibility
and increased Q3 and Q4 occurrence was observed regardless of
antibiotic class (Supplementary Figure S2). The only exception
was ceftriaxone (CRO), where both CRO-resistant and CROsusceptible isolates displayed higher incidence during Q3 and
Q4 compared to Q1 and Q2, though seasonal changes were of
lower magnitude among CRO-resistant isolates (Supplementary
Figure S2). Lastly, antibiotic resistance rates were lower during
Q3 and Q4 compared to Q1 and Q2, regardless of tested antibiotic (Supplementary Figure S3A), classification as HA or nHA,
and tissue source (Supplementary Figure S3B).
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